PT  - JOURNAL ARTICLE
AU  - Qiao, Shan
AU  - Li, Zhenlong
AU  - Zhang, Jiajia
AU  - Sun, Xiaowen
AU  - Garrett, Camryn
AU  - Li, Xiaoming
TI  - Social capital, urbanization level, and COVID-19 vaccination uptake in the United States: A national level analysis
AID  - 10.1101/2022.03.04.22271917
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.04.22271917
4099  - http://medrxiv.org/content/early/2022/03/07/2022.03.04.22271917.short
4100  - http://medrxiv.org/content/early/2022/03/07/2022.03.04.22271917.full
AB  - Vaccination remains the most promising mitigation strategy for the COVID-19 pandemic. However, existing literature shows significant disparities in vaccination uptake in the United States. Using publicly available national-level data, we aimed to explore if county-level social capital can further explain disparities in vaccination uptake rate adjusting for demographic and social determinants of health (SDOH) variables; and if association between social capital and vaccination uptake may vary by urbanization level. Bivariate analyses and hierarchical multivariable quasi-binomial regression analysis were conducted, then the regression analysis was stratified by urban-rural status. The current study suggests that social capital contributes significantly to the disparities of vaccination uptake in the US. The results of stratification analysis show common predictors of vaccine uptake but also suggest various patterns based on urbanization level regarding the associations of COVID-19 vaccination uptake with SDOH and social capital factors. The study provides a new perspective to address disparities in vaccination uptake through fostering social capital within communities, which may inform tailored public health intervention efforts in enhancing social capital and promoting vaccination uptake.Competing Interest StatementThe authors have declared no competing interest.Funding Statementthe project is funded by the CDC (grant#: U48DP006401)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves only openly available human data, which can be obtained from CDC, US census American Community Survey, AIDSVu, Social Capital Index project .I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data are from openly available data sets. https://data.cdc.gov/Vaccinations/Vaccine-Hesitancy-for-COVID-19-County-and-local-es/q9mh-h2tw https://www.census.gov/newsroom/press-releases/2019/acs-5-year.html https://aidsvu.org/ https://www.lee.senate.gov/scp-index https://www.cdc.gov/nchs/data_access/urban_rural.htm